Tartaric Acid
Medchemexpress LLC D-(-)-tartaric acid | 147-71-7 | MFCD00004238 | 150.09 g/mol | C4H6O6 | 10g
D-Tartaric acid (D-(-)-Tartaric acid) is a polyhydroxy acid D-Tartaric acid crystal structure is studied by X-ray and neutron diffraction[1][2]
Selleck Chemical LLC D-(-)-Tartaric acid S3134-100mg
D-(-)-Tartaric acid is the unnatural isomer of Tartaric acid which is an important chiral chemical building block with broad industrial and scientific applications
TARGETMOL CHEMICALS INC ENMD-2076 5MG
Also available in 1 mL, 1 mg, 2 mg, 10 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRalpha. Purity 98%
Medchemexpress LLC DL-tartaric acid (anhydrous) | 133-37-9 | MFCD00071626 | 98.0% | 10g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC D-(-)-tartaric acid diisopropyl ester | 62961-64-2 | MFCD00008876 | >98.0% | 234.25 g/mol | C10H18O6 | 25 G
D-(-)-Tartaric acid diisopropyl ester (CAS 62961-64-2) is a chiral organic reagent used in enantioselective synthesis, biochemical assays, and research applications. It is a colorless to light yellow liquid with formula C10H18O6 and molecular weight 234.25 g/mol, supplied in laboratory pack sizes for analytical and synthetic use. Intended for research use only.
- Chiral building block for asymmetric synthesis
- Suitable for biochemical assays and method development
- High purity, typically >98%
- Available in multiple laboratory pack sizes
- Stored at low temperatures to maintain stability
Apexbio Technology LLC ENMD-2076 934353-76-1 10mg
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
eMolecules (+)-Diacetyl-d-tartaric acid | 66749-60-8 | MFCD02093460 | 1g
Combi-Blocks | (+)-Diacetyl-d-tartaric acid | 1g | 495744747 | QG-6219 | 95.000 | 66749-60-8 | MFCD02093460 | 234.160 | C8H10O8
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC D-(-)-tartaric acid diisopropyl ester | 62961-64-2 | MFCD00008876 | >98.0% | 234.25 g/mol | C10H18O6 | 10 G
D-(-)-Tartaric acid diisopropyl ester is the diisopropyl ester derivative of D-tartaric acid used as a chiral building block and biochemical reagent for research applications. It is supplied as a colorless to light yellow liquid (MW 234.25 g/mol) and is commonly used in enantioselective synthesis and chiral derivatization workflows.
- Chiral building block for asymmetric synthesis.
- Useful for chiral derivatization and analytical methods.
- Liquid form facilitates solution-phase reactions and handling.
- Compatible with common organic solvents.
- Storage-stable when kept under recommended temperatures.